Tag Archives: Vic Neufeld

Aphria Liberty Health

Aphria Begins to Divest of its Equity Investment in Passive US Assets

Aphria Begins to Divest of its Equity Investment in Passive US Assets

LEAMINGTON, Ontario, Feb. 5, 2018 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or USOTCQB: APHQF) today announced that it entered into a purchase and sale agreement to sell 26,716,025 shares representing all its shares in Liberty Health Sciences Inc. (“Liberty”) that are not subject to Canadian Securities Exchange (“CSE”) escrow requirements.

Aphria Liberty Health sale agreement

Aphria And Liberty Health Sciences Announce Definitive Agreement For Sale Of Aphria’s Investment In Copperstate Farms To Liberty

LEAMINGTON AND TORONTO, Ontario, Feb. 2, 2018 /Weed Wire/ — Aphria Inc. (TSX:APH or OTCQB:APHQF) (“Aphria”) and Liberty Health Sciences Inc. (CSE:LHS or OTCQB:LHSIF) (“Liberty”) jointly announce that they have entered into a definitive agreement (the “Agreement”) with respect to the sale (the “Transaction”) of Aphria’s subsidiary Aphria (Arizona) Inc. and its sole holdings being the minority membership interests in Copperstate Farms, LLC and Copperstate Farms Investors, LLC (collectively “Copperstate”) to Liberty for a purchase price of $20 million (“Purchase Price”).

Licensed Marijuana Producer Aphria Signs Deal to Buy Nuuvera

Licensed Marijuana Producer Aphria Signs Deal to Buy Nuuvera

Licensed marijuana producer Aphria Inc. announced an agreement Monday to buy medical cannabis firm Nuuvera Inc. in a cash-and-stock deal that it says values the company at $826 million.

Aphria Stock Soars Following Announcement of Medical Cannabis Deal With Shoppers Drug Mart

Aphria Stock Soars After Announcement of Cannabis Deal With Shoppers Drug Mart

Following market close on Dec. 4, 2017, Aphria Inc. (TSX:APH), an Ontario-based licensed producer of medical cannabis, made headlines when it announced that it had entered into an agreement to be the medical cannabis supplier for Shoppers Drug Mart, a Canadian pharmacy chain.

Shares of Canada's Aphria Slump as Marijuana Faces Regulatory Risk

Shares of Canada’s Aphria Slump as Marijuana Faces Regulatory Risk

Shares of Canadian marijuana company Aphria Inc sank on Tuesday, after the operator of the Toronto Stock Exchange said cannabis companies with U.S. interests would come under heightened scrutiny and could be delisted.

Aphria Liberty Health

Aphria Launches US Expansion Strategy

LEAMINGTON, Ontario, April 4, 2017 /Weed Wire/ – Aphria Inc. (“Aphria” or the “Company”) (TSX:APH)(OTCQB:APHQF) is pleased to announce the launch of its US expansion strategy through a strategic lead investment in an entity to be renamed Liberty Health Sciences Inc. (“Liberty”) that will operate in the United States under the brand “Aphria USA”.

Aphria Liberty Health

Aphria Strengthens US Investment Platform, Increases Position in Copperstate Farms Investors to 18.5%

LEAMINGTON, Ontario, March 27, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX:APH)(OTCQB:APHQF), through its subsidiary Aphria (Arizona) Inc., is pleased to announce that it made an additional investment of $3 million (USD) in Copperstate Farms Investors, LLC (“Investors”).

Aphria

Aphria Continues Success Story With TSX Listing

LEAMINGTON, Ontario, March 21, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF), a Health Canada Licensed Producer of medical cannabis products, today announced that the common shares (the “Common Shares”) of the Company will begin trading on the Toronto Stock Exchange (“TSX”) as of the open of the market on March 22, 2017.

Aphria

Aphria Receives Conditional Approval to Graduate to the TSX

LEAMINGTON, Ontario, Feb. 6, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce it has received conditional approval from the Toronto Stock Exchange (the “TSX”) to graduate from the TSX Venture Exchange and list its common shares on the TSX.

Aphria

Aphria’s Vision to be Reality – Part IV Expansion Project to Increase Greenhouse Growing Space to 1 Million Square Feet

LEAMINGTON, Ontario, Jan. 16, 2017 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that its Board approved a $137 million capital project, known internally as Part IV expansion.

Aphria

Aphria Continues Expansion Strategy

LEAMINGTON, Ontarion, Dec. 14, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement to acquire 200 acres of fully serviced vacant land for $6.24 million located at 521 Mersea Road 8, Leamington, Ontario.

Aphria

Aphria Welcomes Arlene Dickinson to its Board of Directors

LEAMINGTON, Ontario, Oct. 28, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) is pleased to announce that Arlene Dickinson was elected as a new director at the Company’s annual general meeting held on October 27, 2016.

massroots_aphria_combo

Aphria and MassRoots Partner in One of First International Collaborations between Cannabis Companies

LEAMINGTON, Ontario, Oct. 18,2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX-V: APH or USOTCQB: APHQF) one of the leading Canadian licensed producers of medical cannabis, and MassRoots, Inc. (OTCQB:MSRT), one of the largest technology platforms for the cannabis industry, are pleased to announce they have entered into one of the first international partnerships between cannabis companies.

Aphria

Aphria Announces Licence Amendment

LEAMINGTON, Ontario, Sept. 26, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced an amendment to is licence by Health Canada, allowing it to grow up to 3,600 kilograms of dried cannabis and to sell up to 2,800 kilograms of dried cannabis, over the next year.

Aphria

Aphria Finalizes Licensing Deal With Tokyo Smoke

TORONTO, Ontario, Sept. 19, 2016 /Weed Wire/ — Aphria Inc. (“Aphria”) (TSX VENTURE:APH)(OTCQB:APHQF), in connection with its previously announced licensing deal with Tokyo Smoke, a premium cannabis-oriented lifestyle brand, has issued to Tokyo Smoke 38,759 common shares of Aphria and 200,000 common share purchase warrants exercisable for a period of 5 years at an exercise price of $3.14 per warrant.

Aphria

Aphria to Triple Its Production Space as it Starts Part III Expansion

LEAMINGTON, Ontario, Sept.16,2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH) (OTCQB:APHQF) is pleased to announce that its Board of Directors approved a fully funded $24.5 million capital project as the first phase of its Part III expansion.

Aphria

Aphria Partners With Leading International Consumer Lifestyle Brand Tokyo Smoke

TORONTO, Sept. 7, 2016 /Weed Wire/ — Today Aphria Inc. (“Aphria”) (TSX VENTURE:APH) (OTCQB:APHQF), one of Canada’s leading licensed producers of medical cannabis, announced a groundbreaking licensing deal with Tokyo Smoke, a premium cannabis-oriented lifestyle brand.

MedLab LTD

Medlab and Aphria Complete Cannabis Supply Deal Ahead of Cannabis Human Trial

LEAMINGTON, Ontario, Aug. 22, 2016 /Weed Wire/ — Medical life science company, Medlab Clinical Limited (ASX:MDC), has signed a significant cannabis supply agreement with Canadian licenced producer of medical marijuana, Aphria Inc. (TSX VENTURE:APH)(OTCQB:APHQF).

Aphria

Aphria Accelerates Expansion Strategy

LEAMINGTON, Ontario, Aug. 19, 2016 /Weed Wire/ — Aphria Inc. (“Aphria” or the “Company”) (TSX VENTURE:APH)(OTCQB:APHQF) announced today that the Company entered into a purchase and sale agreement with DiNiro Farms Inc. (“DiNiro”) to acquire 11 acres of additional property adjacent to its existing campus for a $2.1 million cash payment.

Canadian

Canadian Producer of Medical Cannabis Prepares to Buy More Land

Aphria Inc., a Canadian producer, supplier, and seller of medical cannabis, has entered into an agreement with DiNiro Farms Inc. to buy 11 acres adjacent to its facilities in Leamington, Ontario, according to a press release. The 11 acres, which include 345,000 square feet of greenhouse space, will be purchased for $2.1 million in cash.

Esev Aphira

ESEV Genetics Scores With Canada’s Aphria to Create Strongest Strains

LEAMINGTON, Ontario, Feb. 1, 2016 /Weed Wire/ — Aphria Inc (TSX VENTURE:APH), one of Canada’s leading large scale producers of medical-grade cannabis, partners with pioneering ESEV Genetics to develop and bring to market the highest quality strains of cannabis available to treat a range of medical conditions.


Top